跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HK-4
首页
药物
HK-4
HK-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Transfection complexes
US 7256043 B2
申请人: ICH PRODUCTIONS LTD
优先权: 2001
US
2 件公开
A hot pot flavoring containing rheum acuminatum Hook. f. et Thoms. ex HK. and capable of relieving rigidity of muscles and activating collaterals and a preparing method thereof
CN 107535999 A
申请人: HARBIN LINGCHUN WEIDAO FOOD DEV CO LTD
优先权: 2016
CN
一种氟氧头孢母核的合成方法
CN 107722042 B
优先权: 2017
CN
靶向铁死亡的纳米药在治疗急性肾损伤中的应用
CN 114699372 B
申请人: 浙江大学医学院附属第四医院
优先权: 2022
CN
Honokiol derivative with anti-tumor activity as well as preparation method and application of honokiol derivative
CN 118580199 A
申请人: CHONGQING INST GREEN & INTELLIGENT TECH CAS
优先权: 2023
CN
Ferrocene-isoxazole hybrid compound as well as preparation method and application thereof
CN 116554235 A
申请人: AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
优先权: 2023
CN
CYTOPROTECTIVE AGENT AGAINST FERROPTOSIS
WO 2026100445 A1
申请人: WATANABE OYSTER LABORATORY CO LTD
优先权: 2024
WO
Prodrug nano-platform for activating ferroptosis and eliminating senescent cells as well as preparation method and application of prodrug nano-platform
CN 120285229 A
申请人: UNIV ZHEJIANG SHUREN
优先权: 2025
CN
Preparation method and application of nanoparticles
CN 120459041 A
申请人: UNIV ANHUI MEDICAL
优先权: 2025
CN
Euphorbia nigra extract and application of active ingredients thereof in preparation of medicine for treating chronic kidney disease
CN 120501729 A
申请人: UNIV DALI
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈